Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Spectrum Pharma Inc
(NQ:
SPPI
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Jul 31, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Spectrum Pharma Inc
< Previous
1
2
3
4
5
Next >
Marathon Oil To Rally Around 65%? Plus This Analyst Cuts PT On Twilio By 55%
November 28, 2022
Raymond James raised the price target on Marathon Oil Corporation (NYSE: MRO) from $37 to $48. Raymond James analyst John Freeman maintained a Strong Buy rating on the stock. Marathon Oil shares fell...
Via
Benzinga
After FDA Rejection, Spectrum Shelves Development On Poziotinib
November 25, 2022
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
November 25, 2022
Via
Benzinga
Why Lufax Holding Shares Are Trading Lower By Over 11%; Here Are 21 Stocks Moving Premarket
November 25, 2022
Gainers VEON Ltd. (NASDAQ: VEON) shares rose 31.1% to $0.6095 in pre-market trading after the company agreed to sell its Russian business, Vimpelcom for 130 billion roubles ($2.2 billion).
Via
Benzinga
Expert Ratings for Spectrum Pharmaceuticals
November 16, 2022
Via
Benzinga
Despite Regulatory Setback, Spectrum Still "Unique Investment Opportunity," Says Analyst
September 23, 2022
Via
Benzinga
After Regulatory Setback, Spectrum Pharma Secures Up To $65M In Debt Funding
September 23, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 16, 2022
November 16, 2022
Upgrades
Via
Benzinga
Provention Bio's Second Try, Apellis's Eye Disorder Drug Review, 3 Adcom Verdicts And More: November's Key PDUFA Catalysts Biotech Investors Must Know
November 01, 2022
October proved to be a mixed month for the Food and Drug Administration’s regulatory decisions. Two new molecular entities, or NMEs, were approved during the month, bringing the tally for the...
Via
Benzinga
FDA's Adcomm Gives Thumbs Down To Spectrum Pharmaceuticals' Lung Cancer Candidate
September 23, 2022
Via
Benzinga
Earnings Scheduled For November 10, 2022
November 10, 2022
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report earnings for its third quarter.
Via
Benzinga
AstraZeneca-Merck's Prostate Cancer Combo Drug, 3rd Try For scPharma, 3 FDA Panel Decisions And More: October's Key PDUFA Catalysts Biotech Investors Must Know
October 02, 2022
Most FDA decisions scheduled for September yielded positive results, but there were stray disappointments as well. Seven new molecular entities, or NMEs, were approved during the month, taking the...
Via
Benzinga
Why NanoVibronix Shares Surged Over 25%; Here Are 82 Biggest Movers From Friday
September 26, 2022
Gainers Golden Sun Education Group Limited (NASDAQ: GSUN) shares surged 92.1% to settle at $52.89 on Friday.
Via
Benzinga
Dow Hits New 2022 Low; Gold Falls Sharply
September 23, 2022
U.S. stocks extended losses toward the end of trading, with the Dow Jones dropping to a fresh low for the year.
Via
Benzinga
Why Shares Of Oil & Gas Companies Are Trading Lower, Here Are 62 Stocks Moving In Friday's Mid-Day Session
September 23, 2022
Gainers Kiromic BioPharma, Inc. (NASDAQ: KRBP) shares jumped 87% to $0.4791. Kiromic BioPharma, said on Sept. 15, that the company received letter from the Nasdaq that co. has been granted 180-day...
Via
Benzinga
Nasdaq Tumbles Over 200 Points; Crude Oil Drops Sharply
September 23, 2022
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping more than 200 points on Friday.
Via
Benzinga
11 Health Care Stocks Moving In Friday's Pre-Market Session
September 23, 2022
Gainers Rubius Therapeutics (NASDAQ:RUBY) shares moved upwards by 30.46% to $0.59. The market value of their outstanding shares is at $53.5 million.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
September 23, 2022
We're breaking down the biggest pre-market stock movers for Friday morning alongside the news that traders need to know about!
Via
InvestorPlace
Why T2 Biosystems Is Trading Higher By 18%; Here Are 28 Stocks Moving Premarket
September 23, 2022
Gainers HHG Capital Corporation (NASDAQ: HHGC) shares rose 42.1% to $14.56 in pre-market trading.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
September 22, 2022
Gainers Genfit (NASDAQ:GNFT) shares increased by 27.4% to $5.12 during Thursday's after-market session. The market value of their outstanding shares is at $255.0 million.
Via
Benzinga
With Upcoming Contentious Meeting, This Analyst Cuts Price Target On Spectrum Pharma
September 21, 2022
Via
Benzinga
Why SOBR Safe Shares Surged Around 233%; Here Are 68 Biggest Movers From Yesterday
September 21, 2022
Gainers
Via
Benzinga
Dow Dips 400 Points; Ford Shares Slide
September 20, 2022
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping 400 points on Tuesday.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
September 20, 2022
Via
Benzinga
Why Virios Therapeutics Is Trading Lower By 75%, Here Are 44 Stocks Moving In Tuesday's Mid-Day Session
September 20, 2022
Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares jumped 51% to $0.4957. Crown ElectroKinetics, last month, posted a Q4 net loss of $4.5 million.
Via
Benzinga
Nasdaq Down 50 Points; Crude Oil Falls Sharply
September 20, 2022
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping around 50 points on Tuesday.
Via
Benzinga
Spectrum Plunges After FDA Casts Doubts On Its Lung Cancer Candidate
September 20, 2022
Ahead of an adcomm meeting for Spectrum Pharmaceutical Inc (NASDAQ: SPPI), FDA released briefing documents related to poziotinib for treating patients with previously treated locally advanced or...
Via
Benzinga
Looking Into Spectrum Pharmaceuticals's Recent Short Interest
September 13, 2022
Spectrum Pharmaceuticals's (NASDAQ:SPPI) short percent of float has risen 14.81% since its last report. The company recently reported that it has 4.05 million shares sold short,...
Via
Benzinga
What Is Going on With Spectrum Pharmaceuticals (SPPI) Stock Today?
September 12, 2022
Spectrum Pharmaceuticals received regulatory approval for its oncology-related infection-reducing therapeutic, bolstering SPPI stock.
Via
InvestorPlace
Why Ventyx Biosciences Is Trading Higher By 70%, Here Are 46 Stocks Moving In Monday's Mid-Day Session
September 12, 2022
Gainers Ventyx Biosciences, Inc. (NASDAQ: VTYX) shares jumped 70.4% to $39.37 after Oppenheimer maintained an Outperform rating on the stock and raised its price target from $40 to $65.
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.